The Oncology Institute Inc. Common Stock (TOI)
FairStock Score: 34/100 — RISKY
Key Financials
| Current Price | $6.2 |
| Market Cap | $322M |
| P/E Ratio | -17.71 |
| ROE | —% |
| Dividend Yield | —% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for businesses with durable economics, honest accounting, and a price that leaves room for error. The Oncology Institute is a $321.7 million market-cap operator in cancer care. In the latest reported quarter, 2026-Q2, revenue was $161.3 million, but net income was negative $9.8 million, a -6.07% margin. Trailing free cash flow was negative $3.3 million, and FairStock's FCF yield is -1.0%. Its return on capital employed is -12.30%, the Altman Z-Score is -0.23, and the Piotroski F-Score is 5/9. At the $6.20 close on 2026-08-11, the P/E is -17.71 because EPS is -$0.35; there is no positive earnings anchor. Revenue growth of 41.22% and profit growth of 87.28% are striking, but they come from a loss-making base and the provided data does not specify the periods. Growth that consumes cash is not owner earnings. The business may have local scale in oncology services, specialty pharmacy, and clinical trials, but I see no clear durable moat in these numbers. The FairStock Score is 34/100 and the Lynch category is none because only 0 years of filed results exist, versus the three needed. The stock sits in a $2.32-$7.05 52-week range, closer to the high than the low. This is a speculative growth story, not a Graham bargain.
In plain English: The Oncology Institute provides cancer care services, including doctor services, infusion, specialty pharmacy, and clinical trials. The business is growing revenue quickly but still loses money and spends more cash than it brings in, so the financial picture looks weak. At $6.20, the shares do not look cheap compared with current profits, because there are no positive profits yet.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-08-11 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer